Polycab India promoters plan a ₹888 crore block deal, while Tata Steel invests ₹4,055 crore in its overseas arm TSHP. Piramal Enterprises gets NCLT nod to merge with Piramal Finance, and Lupin receives tentative US FDA approval for a generic HIV drug. Dalmia Bharat faces ED land attachment under PMLA, and Glenmark, IPCA Labs, and Newgen Software announce key pharma and IT deals. Other developments include Akzo Nobel stake sale, Birla Corp’s RCCPL winning a Telangana limestone block, and GPT Infraprojects appointing Om Tantia as Co-Chairman. Here are few stocks to watch ahead of Thursday’s trading session.
